Modulation of the in vitro cardiotoxicity of doxorubicin by flavonoids (Q71581719)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7497597%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

Modulation of the in vitro cardiotoxicity of doxorubicin by flavonoids (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7497597%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

B C Hüsken

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7497597%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

J de Jong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7497597%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

B Beekman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7497597%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

R C Onderwater

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7497597%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

W J van der Vijgh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7497597%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

A Bast

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7497597%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7497597%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

19 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7497597%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7497597%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7497597%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

55-62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7497597%20AND%20SRC:MED&resulttype=core&format=json

Effect of anthracycline antibiotics on oxygen radical formation in rat heart

19 October 2019

cites work

1 reference

12 December 2020

Metabolism and reactions of quinoid anticancer agents

1 reference

12 December 2020

Reduction of O2 by iron-adriamycin

1 reference

12 December 2020

Experimental animal models of adriamycin cardiotoxicity

1 reference

12 December 2020

Free radical formation from anthracycline antitumour agents and model systems--I. Model naphthoquinones and anthraquinones

1 reference

12 December 2020

Transfer of ferritin-bound iron to adriamycin

1 reference

12 December 2020

Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of a doxorubicin-iron (III) complex

1 reference

12 December 2020

Risk factors for doxorubicin-induced congestive heart failure

1 reference

12 December 2020

Protection against lipid peroxidation by a microsomal glutathione-dependent labile factor

1 reference

12 December 2020

Flavonoids, a class of natural products of high pharmacological potency

1 reference

12 December 2020

Cardioprotective properties of O-(beta-hydroxyethyl)-rutosides in doxorubicin-pretreated BALB/c mice

1 reference

12 December 2020

Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation

1 reference

12 December 2020

Effect of pretreatment with ICRF-187 on the total cumulative dose of doxorubicin tolerated by beagle dogs

1 reference

12 December 2020

The Adriamycin (doxorubicin)-induced inactivation of cytochrome c oxidase depends on the presence of iron or copper

1 reference

12 December 2020

Characterization of the cycle of iron-mediated electron transfer from Adriamycin to molecular oxygen

1 reference

12 December 2020

Metal binding by pharmaceuticals. Part 2. Interactions of Ca(II), Cu(II), Fe(II), Mg(II), Mn(II) and Zn(II) with the intracellular hydrolysis products of the antitumour agent ICRF 159 and its inactive homologue ICRF 192

1 reference

12 December 2020

Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer

1 reference

12 December 2020

The iron(III) and copper(II) complexes of adriamycin promote the hydrolysis of the cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane).

1 reference

12 December 2020

Iron-mediated formation of an oxidized adriamycin free radical

1 reference

12 December 2020

Isolated mouse atrium as a model to study anthracycline cardiotoxicity: the role of the beta-adrenoceptor system and reactive oxygen species

1 reference

12 December 2020

Cytochrome c reduction by semiquinone radicals can be indirectly inhibited by superoxide dismutase

1 reference

12 December 2020

In vitro evidence for direct complexation of ADR-529/ICRF-187 [(+)-1,2-bis-(3,5-dioxo-piperazin-1-yl)propane] onto an existing ferric-anthracycline complex

1 reference

12 December 2020

Stability of flavonoid complexes of copper(II) and flavonoid antioxidant activity

1 reference

12 December 2020

The interaction of the cardioprotective agent ICRF-187 [+)-1,2-bis(3,5-dioxopiperazinyl-1-yL)propane); its hydrolysis product (ICRF-198); and other chelating agents with the Fe(III) and Cu(II) complexes of adriamycin

1 reference

12 December 2020

Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex

1 reference

12 December 2020

Differences in O2 reduction by the iron complexes of adriamycin and daunomycin: the importance of the sidechain hydroxyl group

1 reference

12 December 2020

Iron(III)-adriamycin and Iron(III)-daunorubicin complexes: physicochemical characteristics, interaction with DNA, and antitumor activity

1 reference

12 December 2020

Role of daunosamine and hydroxyacetyl side chain in reaction with iron and lipid peroxidation by anthracyclines.

1 reference

12 December 2020

The isolated mouse atria as a new model for testing cardioactive drugs with special reference to doxorubicin (Adriamycin)

1 reference

12 December 2020

Effects of (+)-1,2-bis(3,5-dioxopiperazin-1-yl)propane (ADR-529) on iron-catalyzed lipid peroxidation

1 reference

12 December 2020

Nonenzymatic oxygen activation and stimulation of lipid peroxidation by doxorubicin-copper

1 reference

12 December 2020

DNA strand scission induced by adriamycin and aclacinomycin A

1 reference

12 December 2020

The oxidation of citrate, isocitrate and cis-aconitate by isolated mitochondria

1 reference

12 December 2020

Self-reduction of the iron(III)-doxorubicin complex

1 reference

12 December 2020

Superoxide dismutase-inhibitible reduction of cytochrome c by the alloxan radical. Implications for alloxan cytotoxicity

1 reference

12 December 2020

NADPH- and adriamycin-dependent microsomal release of iron and lipid peroxidation.

1 reference

12 December 2020

Evidence of the selective alteration of anthracycline activity due to modulation by ICRF-187 (ADR-529).

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00685629

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7497597%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference